{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T07:02:19Z","timestamp":1784444539032,"version":"3.55.0"},"reference-count":37,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP20K20618"],"award-info":[{"award-number":["JP20K20618"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP21H02829"],"award-info":[{"award-number":["JP21H02829"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP21K18288"],"award-info":[{"award-number":["JP21K18288"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Palliative Medicine Reports"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Dyspnea is one of the most distressing symptoms in patients with advanced cancer. Although systemic opioids are recommended as first-line pharmacologic treatment, 30\u201350% of patients do not achieve adequate relief. Midazolam is often used for persistent dyspnea despite opioid administration; however, robust evidence supporting its efficacy as a second-line treatment remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To evaluate the feasibility of a randomized controlled trial assessing the efficacy and safety of continuous subcutaneous midazolam infusion as second-line treatment for persistent dyspnea despite morphine administration in hospitalized patients with advanced cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A protocol for a multicenter, randomized, double-blind, placebo-controlled feasibility trial (J-SUPPORT2201\/JORTC-PAL22) is described. The trial is being conducted at nine sites in Japan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Population:<\/jats:title>\n                    <jats:p>Participants are hospitalized adult patients with advanced cancer who are not receiving active anticancer treatment and who experience dyspnea at rest (Integrated Palliative Care Outcome Scale dyspnea score \u22652) despite continuous morphine infusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention\/Control:<\/jats:title>\n                    <jats:p>Protocol treatment includes standardized morphine escalation plus continuous subcutaneous infusion of midazolam (9 or 6 mg\/day for vulnerable patients) or placebo for 24 hours.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements:<\/jats:title>\n                    <jats:p>The primary endpoint is feasibility, defined as completion of protocol treatment at 24 hours. Secondary endpoints include dyspnea intensity, anxiety, rescue morphine use, communication, adverse events, and 30-day survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This feasibility trial will provide methodological insights and preliminary clinical data regarding midazolam as a second-line option for persistent dyspnea despite morphine infusion in patients with advanced cancer and help design future confirmatory trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/26892820261461866","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:35:42Z","timestamp":1784295342000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Study Protocol for Feasibility Randomized, Placebo-Controlled Trial of Efficacy of Midazolam as the Second-Line Treatment for Dyspnea in Patients with Advanced Cancer"],"prefix":"10.1177","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9955-1667","authenticated-orcid":false,"given":"Satoru","family":"Miwa","sequence":"first","affiliation":[{"name":"Seirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5489-9395","authenticated-orcid":false,"given":"Masanori","family":"Mori","sequence":"additional","affiliation":[{"name":"Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, Hamamatsu, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Oyamada","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, JORTC Data Center, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuhiro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ariyoshi","sequence":"additional","affiliation":[{"name":"Department of Data Management, JORTC Data Center, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Internal Medicine, NHO Kinki Chuo Chest Medical Center, Sakai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozue","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Tasaki","sequence":"additional","affiliation":[{"name":"Palliative Care Center, Kumamoto University Hospital, Kumamoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Hatano","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Kenseikai Yoshida Hospital, Nara, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Nishijima","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Daini Kyoritsu Hospital, Kawanishi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayo","family":"Aiki","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, National Hospital Organization Osaka National Hospital, Osaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hagimoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory, Allergic Diseases Internal Medicine, Tosei General Hospital, Seto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Kuriyama","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, School of Medicine, Wakayama Medical University, Wakayama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Okuda","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, School of Medicine, Wakayama Medical University, Wakayama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimon","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Department of Sociology, Graduate School of Arts and Letters, Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Palliative Therapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Clinical Assessment, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ishiguro","sequence":"additional","affiliation":[{"name":"Breast Oncology Service, Saitama Medical University International Medical Center, Hidaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadamoto","family":"Zenda","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Psycho\u2010Oncology, National Cancer Center Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hui","sequence":"additional","affiliation":[{"name":"Department of Palliative, Rehabilitation, and Integrative Medicine, MD Anderson Cancer Center, Houston, Texas, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Morita","sequence":"additional","affiliation":[{"name":"Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, Hamamatsu, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Konan Medical Center, Kobe, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201111-2042ST"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2014.09.003"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2021.06.005"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2020.11.037"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-05081-9"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03465"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-001038"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2023.0667"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(97)00022-X"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2005.06.009"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/026921639701100208"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/02692163211057754"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2019.04.007"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2022.11.018"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1089\/pmr.2023.0076"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyab193"},{"key":"e_1_3_6_18_1","unstructured":"17.Ministry of Health Labour and Welfare Japan. Clinical Trials Act (Act No. 16 of 2017). 2017. Available from: https:\/\/elaws.e-gov.go.jp\/document?lawid=429AC0000000016 [Last accessed: July28 2025]."},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.3.341"},{"key":"e_1_3_6_20_1","volume-title":"A Practical Guide for Refractory Suffering and Palliative Sedation Therapy in Advanced Cancer Patients","author":"Japanese Society for Palliative Medicine e","year":"2023","unstructured":"19.Japanese Society for Palliative Medicine e. A Practical Guide for Refractory Suffering and Palliative Sedation Therapy in Advanced Cancer Patients, 3rd ed. KANEHRA & Co., Ltd: Tokyo Japan; 2023. [published in Japanese].","edition":"3"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5362"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2015.05.014"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1996"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyy203"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255991"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2009.0229"},{"issue":"7","key":"e_1_3_6_27_1","first-page":"28","article-title":"The clinical global impressions scale: Applying a research tool in clinical practice","volume":"4","author":"Busner J","year":"2007","unstructured":"26.Busner J, , Targum SD. The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry (Edgmont) 2007;4(7):28\u201337.","journal-title":"Psychiatry (Edgmont)"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1191\/026921601678576185"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2021.05.001"},{"key":"e_1_3_6_30_1","unstructured":"29.Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. Available from: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf [Last accessed: September16 2019]."},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.2512\/jspm.11.331"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2107138"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.22.2983"},{"key":"e_1_3_6_34_1","volume-title":"ICH Harmonised Guideline: Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2)","author":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)","year":"2016","unstructured":"33.International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Harmonised Guideline: Integrated Addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2). ICH; 2016."},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2013.03.017"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29437"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2012.0364"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27854"}],"container-title":["Palliative Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/26892820261461866","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/26892820261461866","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/26892820261461866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T06:16:13Z","timestamp":1784441773000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/26892820261461866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"alternative-id":["10.1177\/26892820261461866"],"URL":"https:\/\/doi.org\/10.1177\/26892820261461866","relation":{},"ISSN":["2689-2820","2689-2820"],"issn-type":[{"value":"2689-2820","type":"print"},{"value":"2689-2820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"26892820261461866"}}